125 related articles for article (PubMed ID: 35878716)
1. A Systematic Comparison of Dose Distributions Delivered in
Trofimov AV; Aronow ME; Gragoudas ES; Keane FK; Kim IK; Shih HA; Bhagwat MS
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):501-510. PubMed ID: 35878716
[TBL] [Abstract][Full Text] [Related]
2. 106Ru/106Rh plaque and proton radiotherapy for ocular melanoma: a comparative dosimetric study.
Mourtada F; Koch N; Newhauser W
Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):454-60. PubMed ID: 16604677
[TBL] [Abstract][Full Text] [Related]
3. Influence of tumor shape and location in eye plaque brachytherapy dosimetry.
Studenski MT; Patel NV; Markoe A; Harbour JW; Samuels SE
Brachytherapy; 2020; 19(2):249-254. PubMed ID: 32061535
[TBL] [Abstract][Full Text] [Related]
4. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
[TBL] [Abstract][Full Text] [Related]
6. Quantifying the dosimetric influences of radiation coverage and brachytherapy implant placement uncertainty on eye plaque size selection.
Gagne NL; Rivard MJ
Brachytherapy; 2013; 12(5):508-20. PubMed ID: 23466357
[TBL] [Abstract][Full Text] [Related]
7. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
8. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
Lesperance M; Inglis-Whalen M; Thomson RM
Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
[TBL] [Abstract][Full Text] [Related]
9. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
10. Optic disc dose reduction in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
J Appl Clin Med Phys; 2020 Sep; 21(9):57-70. PubMed ID: 32656945
[TBL] [Abstract][Full Text] [Related]
11. Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions.
Tien CJ; Astrahan MA; Kim JM; Materin M; Chen Z; Nath R; Liu W
Brachytherapy; 2017; 16(5):1057-1064. PubMed ID: 28778599
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric and radiobiologic comparison of
Gorovets D; Gagne NL; Melhus CS
Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
[TBL] [Abstract][Full Text] [Related]
13. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
16. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
Kamrani S; Aghamiri SMR; Hashemi S
Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
[TBL] [Abstract][Full Text] [Related]
17. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
[TBL] [Abstract][Full Text] [Related]
18. Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.
Hegde JV; McCannel TA; McCannel CA; Lamb J; Wang PC; Veruttipong D; Almanzor R; Demanes DJ; Kamrava M
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1843-1850. PubMed ID: 28597076
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
Knutsen S; Hafslund R; Monge OR; Valen H; Muren LP; Rekstad BL; Krohn J; Dahl O
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1159-66. PubMed ID: 11704341
[TBL] [Abstract][Full Text] [Related]
20. Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities - A retrospective study using COMS eye plaques.
Oare C; Sun S; Dusenbery K; Reynolds M; Koozekanani D; Gerbi B; Ferreira C
Phys Med; 2022 Sep; 101():71-78. PubMed ID: 35981450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]